Showing results (851-860 of 1,131) with videos related to

Sort By:
Pageof 114
Biorxiv : the Preprint Server for Biology|October 1, 2025
No Evidence of Direct Activation of Human Neutrophil Responses by Multivalent Prefusion Trimeric SARS-CoV-2 Spike Protein <i>ex vivo</i>Audray Fortin, Sandrine Huot, Elise Caron, et al.
Advances in Therapy|August 10, 2022
Characterizing the Shifting Real-World Treatment Landscape by PD-L1 Testing Status and Expression Level in Advanced Non-Small Cell Lung CancerWenzhen Ge, Ning Wu, Ruben G W Quek, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2013
Cold spot mapping inferred from MRI at time of failure predicts biopsy-proven local failure after permanent seed brachytherapy in prostate cancer patients: implications for focal salvage brachytherapyGilles Crehange, Devan Krishnamurthy, J Adam Cunha, et al.
Scientific Reports|October 21, 2022
Machine learning models for identifying predictors of clinical outcomes with first-line immune checkpoint inhibitor therapy in advanced non-small cell lung cancerYing Li, Matthew Brendel, Ning Wu, et al.
Journal of Atrial Fibrillation|December 19, 2017
Baseline Demographics, Safety, and Patient Acceptance of an Insertable Cardiac Monitor for Atrial Fibrillation Screening: The REVEAL-AF StudySergio Conti, James A Reiffel, Bernard J Gersh, et al.
Journal of Proteomics & Bioinformatics|March 11, 2016
A Quantitative Proteomic Analysis of Urine from Gamma-Irradiated Non-Human PrimatesStephanie D Byrum, Marie S Burdine, Lisa Orr, et al.
Journal of Applied Clinical Medical Physics|April 14, 2016
Assessment of image quality and dose calculation accuracy on kV CBCT, MV CBCT, and MV CT images for urgent palliative radiotherapy treatmentsMareike Held, Florian Cremers, Penny K Sneed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2018
Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A <i>Post Hoc</i> Analysis of the PR.7 TrialPaul Toren, Azik Hoffman, Keyue Ding, et al.
British Journal of Clinical Pharmacology|April 14, 2023
Comprehensive clinical pharmacology characterization of AZD4635 in healthy participants to support dosing considerationsGanesh Moorthy, Gayle Pageau Pouliot, Lorraine Graham, et al.
Molecular Metabolism|January 8, 2026
Targeting DHODH Reveals a Metabolic Vulnerability in AR-positive and AR-negative Prostate Cancer Cells via Pyrimidine Synthesis and Metabolic Crosstalk with the TCA and Urea CyclesMaxime Labroy, Marc-Oliver Paré, Line Berthiaume, et al.
Pageof 114